Nefelie Charalabopoulou’s Post

View profile for Nefelie Charalabopoulou, graphic

Partner at Zepos & Yannopoulos | Head of Healthcare and Life Sciences

🔔 Last Friday, Zepos & Yannopoulos published its 2023 Annual Report 📓. It includes my article on the trends surrounding the #lifesciences industry 💊.    🔊 “Digital health”, “#Healthcare Transformation”, “#AI”, “#ESG”, “Legislative Reform”: These were only a few of the headline issues we saw in 2023 in the life sciences industry, and they will surely continue to be invoked frequently during 2024 and the years to come. As the sector transitions through crucial legislative reform, while still under considerable financial pressure from various angles, incorporating innovative technologies and new business models into the existing modus operandi, and simultaneously adapting to new obligations and ESG requirements may be the biggest hurdle life sciences companies will face in 2024. Many stakeholders are trying to keep pace with an ever-changing environment, and determining which advancements to prioritise, and which to forego, can be a challenging task. Those who cannot keep up will be left behind, as 2024 is likely when industry players will set their course for the coming years.”   📋 Read the full article in the annual report available at https://bit.ly/43Mi0mW   ✨ Among others, you can read insights into #Greece’s business landscape, provided by representatives from key sectors of the Greek economy who share their thoughts on the opportunities and challenges, as well as the thoughts of fellow partners on the drivers and trends in their respective practices.

Zepos & Yannopoulos presents its Annual Report for 2023

Zepos & Yannopoulos presents its Annual Report for 2023

zeya.com

To view or add a comment, sign in

Explore topics